Cargando…
RNA-based therapeutics to treat human fungal infections
In recent decades, RNA-based therapeutics have transitioned from a near impossibility to a compelling treatment alternative for genetic disorders and infectious diseases. The mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are truly groundbreaking, and new adaptati...
Autores principales: | Bruch, Alexander, Kelani, Abdulrahman A., Blango, Matthew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498853/ https://www.ncbi.nlm.nih.gov/pubmed/34635448 http://dx.doi.org/10.1016/j.tim.2021.09.007 |
Ejemplares similares
-
Conidial surface proteins at the interface of fungal infections
por: Blango, Matthew G., et al.
Publicado: (2019) -
Disruption of the Aspergillus fumigatus RNA interference machinery alters the conidial transcriptome
por: Kelani, Abdulrahman A., et al.
Publicado: (2023) -
Fungal Genomics Challenges the Dogma of Name-Based Biosecurity
por: McTaggart, Alistair R., et al.
Publicado: (2016) -
Prophylaxis of Invasive Fungal Infection in Neonates: A Narrative Review for Practical Purposes
por: Ferrando, Giulia, et al.
Publicado: (2023) -
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
por: Gimona, Mario, et al.
Publicado: (2017)